What are surrogate endpoints and how can they support the accelerated approval of new medicines? Where and how are surrogate endpoints being used? In which disease areas and markets can...
Read More
Helen Lilley tells us about her experiences and activities as a medical writer at Mtech Access, supporting projects from local communication materials to global value dossiers to HTA submissions.
How will changes to the structure of primary care impact decision making? How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows...
Read More
Heather Wellam (Senior Consultant – Market Access) explains the cost-effectiveness analysis process in Japan, answering FAQs and exploring challenges and opportunities.
Is data the key to transforming healthcare systems and patient care? What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner...
Read More
Visit our virtual booth We are delighted to announce that we will be exhibiting at The MedTech Forum on 30th May – 1st June in Dublin. The event is MedTech...
Read More
How and where can innovation drive improvements in care and deliver better health for the population? How is the NHS looking to collaborate with key partners across industry and academia?...
Read More
Today the UK Department of Health and Social Care launched a new strategy to boost NHS access to innovative medical technology. Prof Phil Richardson shares his thoughts and reflections on the new policy.
Working with a dedicated market access and health economics and outcomes research (HEOR) consultancy offers significant added value to Pharma and Medical Device companies and can give you the confidence...
Read More
The Mtech Access team reflect on a energising and inspiring ISPOR Europe – with commentary from top 10 influencer Prof Phil Richardson
